Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Siliciano, Janet D, Kajdas, Joleen, Finzi, Diana, Quinn, Thomas C, Chadwick, Karen, Margolick, Joseph B, Kovacs, Colin, Gange, Stephen J +1 more·2003·Nature Medicine

DOI 10.1038/nm880

Cited by (1,001)

Items 101–200 of 1,001

Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
Nadine Bachmann, Chantal von Siebenthal, Valentina Vongrad, Teja Turk, Kathrin Neumann, Niko Beerenwinkel, Jasmina Bogojeska, Jacques Fellay, Volker Röth, Yik Lim Kok et al. · 2019 · Nature Communications
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
Julia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, S. Abigail Smith, Erick White, Gregory K. Tharp, Hasse Walum, Kathleen Busman‐Sahay, Christian R. Aguilera-Sandoval, William O. Thayer et al. · 2020 · Nature
Basics of the virology of HIV-1 and its replication
Saleta Sierra, Bernd Kupfer, Rolf Kaiser · 2005 · Journal of Clinical Virology
The Molecular Basis for Human Immunodeficiency Virus Latency
Mbonye, Uri, Karn, Jonathan · 2017 · Annual Review of Virology
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh Tim Gandhi, Deborah K. McMahon, Ronald J. Bosch, Christina M. Lalama, Joshua C. Cyktor, Bernard J. C. Macatangay, Charles R. Rinaldo, Sharon A. Riddler, Evelyn Hogg, Catherine C. Godfrey et al. · 2017 · PLoS Pathogens
Stability of the Latent Reservoir for HIV‐1 in Patients Receiving Valproic Acid
Janet D'Angelo Siliciano, Jun Lai, Marc Callender, Eleanor Pitt, Hao Zhang, Joseph B. Margolick, Joel E. Gallant, Joseph Cofrancesco, Richard D. Moore, Stephen J. Gange et al. · 2007 · The Journal of Infectious Diseases
Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1
Haili Zhang, Yan Zhou, Cecily Alcock, Tara L. Kieffer, Daphne Monie, Janet D'Angelo Siliciano, Quan Li, Paul A. Pham, Joseph Cofrancesco, Deborah Persaud et al. · 2004 · Journal of Virology
The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit
Jonathan Karn · 2010 · Current Opinion in HIV and AIDS
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
Liang Shan, Kai Deng, Hongbo Gao, Sifei Xing, Adam A. Capoferri, Christine M. Durand, Seyed Alireza Rabi, Gregory M. Laird, Michelle Kim, Nina N. Hosmane et al. · 2017 · Immunity
Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
Szu-Han Huang, Yanqin Ren, Allison S. Thomas, Dora Chan, Stefanie Mueller, Adam R. Ward, Shabnum Patel, Catherine M. Bollard, Carolina Colli Cruz, Sara Karandish et al. · 2018 · Journal of Clinical Investigation
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure
Chun, Tae-Wook, Fauci, Anthony S. · 2012 · AIDS
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion
Marilia Rita Pinzone, Jake VanBelzen, S Weissman, Maria Paola Bertuccio, LaMont Cannon, Emmanuele Venanzi Rullo, Stephen A. Migueles, Richard Brad Jones, Talia M. Mota, Sarah Joseph et al. · 2019 · Nature Communications
Viral Sanctuaries during Highly Active Antiretroviral Therapy in a Nonhuman Primate Model for AIDS
Thomas W. North, Joanne Higgins, Jesse D. Deere, Timothy L. Hayes, Andradi Villalobos, Lourdes Adamson, Barbara L. Shacklett, Raymond F. Schinazi, Paul A. Luciw · 2009 · Journal of Virology
Phenotypic signatures of immune selection in HIV-1 reservoir cells
Weiwei Sun, Ce Gao, Ciputra Adijaya Hartana, Matthew R. Osborn, Kevin B. Einkauf, Xiaodong Lian, Benjamin Bone, Nathalie Bonheur, Tae‐Wook Chun, Eric S. Rosenberg et al. · 2023 · Nature
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
Julio C. C. Lorenzi, Yehuda Z. Cohen, Lillian B. Cohn, Edward F. Kreider, John P. Barton, Gerald H. Learn, Thiago Y. Oliveira, Christy L. Lavine, Joshua A. Horwitz, Allison Settler et al. · 2016 · Proceedings of the National Academy of Sciences
G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4 + T Cells In Vivo
Tara L. Kieffer, Patty Kwon, Richard E. Nettles, Yefei Han, Stuart C. Ray, Robert F. Siliciano · 2005 · Journal of Virology
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis, Nancie M. Archin, Myron S. Cohen, Joseph J. Eron, Guido Ferrari, J. Víctor García, Cynthia L. Gay, Nilu P Goonetilleke, Sarah Joseph, Ronald I. Swanstrom et al. · 2020 · Cell
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells
Hultquist, Judd F., Schumann, Kathrin, Woo, Jonathan M., Manganaro, Lara, McGregor, Michael J., Doudna, Jennifer, Simon, Viviana, Krogan, Nevan J., Marson, Alexander · 2016 · Cell Reports
HIV latency is reversed by ACSS2-driven histone crotonylation
Guochun Jiang, Don X. Nguyen, Nancie M. Archin, Steven A. Yukl, Gema Méndez‐Lagares, Yuyang Tang, Maher M. Elsheikh, George R. Thompson, Dennis J. Hartigan-O’Connor, David M. Margolis et al. · 2018 · Journal of Clinical Investigation
HIV-1 dynamics in vivo: implications for therapy
Viviana R. Simon, David D. Ho · 2003 · Nature Reviews Microbiology
The Paradox of HIV Blood–Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies
Olivia Osborne, Nadia Peyravian, Madhavan Nair, Sylvia Daunert, Michal J. Toborek · 2020 · Trends in Neurosciences
Structural and Molecular Interactions of CCR5 Inhibitors with CCR5
Kenji Maeda, Debananda Das, Hiromi Ogata-Aoki, Hirotomo Nakata, Toshikazu Miyakawa, Yasushi Tojo, Rachael Norman, Yoshikazu Takaoka, Jianping Ding, Gail Ferstandig Arnold et al. · 2006 · Journal of Biological Chemistry
Dynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro
Kersten K. Koelsch, Lin Liu, Richard Haubrich, Susanne J. May, Diane V. Havlir, Huldrych F. Günthard, Caroline C. Ignacio, Paula Campos‐Soto, Susan J. Little, Robert W. Shafer et al. · 2008 · The Journal of Infectious Diseases
Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo
Francesco Roberto Simonetti, Hao Zhang, Garshasb Soroosh, Jiayi Duan, Kyle Rhodehouse, Alison L. Hill, Subul A. Beg, Kevin McCormick, Hayley E. Raymond, Christopher L. Nobles et al. · 2020 · Journal of Clinical Investigation
Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir
Biswajit Das, Curtis N. Dobrowolski, Benjamin G. Luttge, Saba Valadkhan, Nicolas Chomont, Rowena Johnston, Peter Bacchetti, Rebecca Hoh, Monica Gandhi, Steven G. Deeks et al. · 2018 · Proceedings of the National Academy of Sciences
Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones
Jack A. Collora, Runxia Liu, Delia Pinto-Santini, Neal G. Ravindra, Carmela Ganoza, Javier R. Lama, Ricardo Alfaro, Jennifer Chiarella, Serena Spudich, Karam Mounzer et al. · 2022 · Immunity
Where Does HIV Live?
Justin Stebbing, Brian Gazzard, Daniel C. Douek · 2004 · New England Journal of Medicine
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Sophie Bouchat, Jean‐Stéphane Gatot, Kabamba Kabeya, Christelle Cardona, Laurence Colin, Georges Herbein, Stéphane De Wit, Nathan Clumeck, Olivier Lambotte, Christine Rouzioux et al. · 2012 · AIDS
The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
Alexandra J Murray, Kyungyoon J. Kwon, Donna L. Färber, Robert F. Siliciano · 2016 · The Journal of Immunology
Analysis of Human Immunodeficiency Virus Type 1 Transcriptional Elongation in Resting CD4+T Cells In Vivo
Kara G. Lassen, Justin R. Bailey, Robert F. Siliciano · 2004 · Journal of Virology
Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4 + T Cells
Natalia Soriano-Sarabia, Rosalie Bateson, Noelle Dahl, Amanda M. Crooks, JoAnn D. Kuruc, David M. Margolis, Nancie M. Archin · 2014 · Journal of Virology
Establishment and stability of the latent HIV-1 DNA reservoir
Johanna Brodin, Fabio Zanini, Lina Thebo, Christa Lanz, Göran Bratt, Richard A. Neher, Jan Albert · 2016 · eLife
A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy
Jason B. Dinoso, Seyed Alireza Rabi, Joel N. Blankson, Lúcio Gama, Joseph L. Mankowski, Robert F. Siliciano, M. Christine Zink, Janice E. Clements · 2009 · Journal of Virology
Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir
Claudia R. Avalos, Celina Monteiro Abreu, Suzanne E. Queen, Ming Li, Sarah L. Price, Erin N. Shirk, Elizabeth L. Engle, Ellen R. Forsyth, Brandon T. Bullock, Feilim Mac Gabhann et al. · 2017 · mBio
Novel Latency Reversal Agents for HIV-1 Cure
Adam M. Spivak, Vicente Planelles · 2017 · Annual Review of Medicine
Highly Sensitive Methods Based on Seminested Real-Time Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 Unspliced and Multiply Spliced RNA and Proviral DNA
Alexander O. Pasternak, Karen W. Adema, Margreet E. Bakker, Suzanne Jurriaans, Ben Berkhout, Marion T. E. Cornelissen, Vladimir V. Lukashov · 2008 · Journal of Clinical Microbiology
Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR
Timothy J. Henrich, Sébastien Gallien, Jonathan Z. Li, Florencia Pereyra, Daniel R. Kuritzkes · 2012 · Journal of Virological Methods
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Line K. Vibholm, Mariane Høgsbjerg Schleimann, Jesper Falkesgaard Højen, Thomas Benfield, Rasmus Offersen, Katrine Rasmussen, Rikke Olesen, Anders Kirch Dige, Jørgen Steen Agnholt, Judith Grau-Expósito et al. · 2017 · Clinical Infectious Diseases
Prevention, treatment and cure of HIV infection
Raphael J. Landovitz, Hyman M Scott, Steven G. Deeks · 2023 · Nature Reviews Microbiology
Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing
A-M Vandamme, Anders B. Sönnerborg, Mounir Ait‐Khaled, Jan Albert, B Asjo, Lee T. Bacheler, Dénes Bánhegyi, Charles A. Boucher, Françoise Brun‐Vézinet, Ricardo Jorge Camacho et al. · 2004 · Antiviral Therapy
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
Anne‐Mieke Vandamme, Ricardo Jorge Camacho, Francesca Ceccherini‐Silberstein, Andreu de Luca, Lucia Palmisano, Dimitrios N. Paraskevis, Roger Paredes, Mario Poljak, Jean‐Claude Schmit, Vincent Soriano et al. · 2011 · PubMed
Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected Patients
Patrick Ryscavage, Sean G. Kelly, Jonathan Z. Li, P. Richard Harrigan, Babafemi Taiwo · 2014 · Antimicrobial Agents and Chemotherapy
Targeting HIV latency: pharmacologic strategies toward eradication
Sifei Xing, Robert F. Siliciano · 2012 · Drug Discovery Today
Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex
Leonid Yurkovetskiy, Mehmet Hakan Guney, Kyusik Kim, Shih Lin Goh, Sean Matthew McCauley, Ann Dauphin, William E. Diehl, Jeremy Luban · 2018 · Nature Microbiology
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus
Elias Konstantine Halvas, Kevin W. Joseph, Leah D. Brandt, Shuang Guo, Michele D. Sobolewski, Jana L. Jacobs, Camille Tumiotto, John K. Bui, Joshua C. Cyktor, Brandon F. Keele et al. · 2020 · Journal of Clinical Investigation
Elite Suppressors Harbor Low Levels of Integrated HIV DNA and High Levels of 2-LTR Circular HIV DNA Compared to HIV+ Patients On and Off HAART
Erin H. Graf, Angela M. Mexas, Jianqing J. Yu, Farida Shaheen, Megan K. Liszewski, Michele Di Mascio, Stephen A. Migueles, Mark Connors, Una O’Doherty · 2011 · PLoS Pathogens
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner, Sarah Palmer, Adam M. Spivak, Joshua Tisdell Schiffer · 2018 · Nature Communications
HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy
Annie Gosselin, Tomas Raul Wiche Salinas, Delphine Planas, Vanessa Sue Wacleche, Yuwei Zhang, Rémi Fromentin, Nicolas Chomont, Éric A. Cohen, Barbara L. Shacklett, Vikram Mehraj et al. · 2016 · AIDS
Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1–Associated Dementia
Gretja Schnell, Serena Spudich, Patrick R. Harrington, Richard W. Price, Ronald I. Swanstrom · 2009 · PLoS Pathogens
Residual inflammation and viral reservoirs
Marta Massanella, Rémi Fromentin, Nicolas Chomont · 2015 · Current Opinion in HIV and AIDS
Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation
Lillian B. Cohn, Israel Tojal da Silva, Renan Valieris, Amy S. Huang, Julio C. C. Lorenzi, Yehuda Z. Cohen, Joy A. Pai, Allison L. Butler, Marina F. Caskey, Mila Janković et al. · 2018 · Nature Medicine
Sustained Induction of NF-κB Is Required for Efficient Expression of Latent Human Immunodeficiency Virus Type 1
Samuel A. Williams, Hakju Kwon, Lin‐Feng Chen, Warner C. Greene · 2007 · Journal of Virology
Recommendations for measuring HIV reservoir size in cure-directed clinical trials
Mohamed Abdel‐Mohsen, Douglas D. Richman, Robert F. Siliciano, Michel C. Nussenzweig, Bonnie J. Howell, Javier Martínez‐Picado, Nicolas Chomont, Katharine J. Bar, Xu G. Yu, Mathias D. Lichterfeld et al. · 2020 · Nature Medicine
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex
Sheena M. Saayman, Daniel C. Lazar, Tristan A. Scott, Jonathan Ross Hart, Mayumi M. Takahashi, John Burnett, Vicente Planelles, Kevin V. Morris, Marc S. Weinberg · 2015 · Molecular Therapy
Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
Rajesh Tim Gandhi, Joshua C. Cyktor, Ronald J. Bosch, Hanna Mar, Gregory M. Laird, Albine Martin, Ann C. Collier, Sharon A. Riddler, Bernard J. C. Macatangay, Charles R. Rinaldo et al. · 2020 · The Journal of Infectious Diseases
HIV-1 remission and possible cure in a woman after haplo-cord blood transplant
Jingmei Hsu, Koen van Besien, Marshall Jay Glesby, Savita G. Pahwa, Anne Coletti, Meredith G. Warshaw, Lawrence D. Petz, Theodore Bruce Moore, Ya Hui Chen, Suresh Pallikkuth et al. · 2023 · Cell
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
Natalie F. McMyn, Joseph Varriale, Emily J. Fray, Carolin Zitzmann, H. H. B. Macleod, Jun Lai, Anushka Singhal, Milica Moskovljevic, Mauro A. Garcia, Brianna M. Lopez et al. · 2023 · Journal of Clinical Investigation
HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
Maud Mavigner, Pierre Delobel, Michelle Cazabat, Martine Dubois, Fatima-Ezzahra L’Faqihi-Olive, Stéphanie Raymond, Christophe Pasquier, Bruno Marchou, Patrice Massip, Jacques Izopet · 2009 · PLoS ONE
Anti-apoptotic Protein BIRC5 Maintains Survival of HIV-1-Infected CD4+ T Cells
Hsiao-Hsuan Kuo, Rushdy Ahmad, Guinevere Q. Lee, Ce Gao, Hsiao-Rong Chen, Zhengyu Ouyang, Matthew J. Szucs, Dhohyung Kim, Athe M. N. Tsibris, Tae‐Wook Chun et al. · 2018 · Immunity
Cell-associated HIV RNA: a dynamic biomarker of viral persistence
Alexander O. Pasternak, Vladimir V. Lukashov, Ben Berkhout · 2013 · Retrovirology
Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency
Kien Nguyen, Biswajit Das, Curtis N. Dobrowolski, Jonathan Karn · 2017 · mBio
A long-term latent reservoir for HIV-1: discovery and clinical implications
Janet D'Angelo Siliciano · 2004 · Journal of Antimicrobial Chemotherapy
Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1
Daniel I. S. Rosenbloom, Oliver Elliott, Alison L. Hill, Timothy J. Henrich, Janet D'Angelo Siliciano, Robert F. Siliciano · 2015 · Open Forum Infectious Diseases
Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children
Jintanat Ananworanich, Thanyawee Puthanakit, Piyarat Suntarattiwong, Kulkanya Chokephaibulkit, Stephen John Kerr, Rémi Fromentin, Wendy Bakeman, Jintana Intasan, Apicha Mahanontharit, Sunee Sirivichayakul et al. · 2014 · AIDS
Latency: the hidden HIV-1 challenge
Alessandro Marcello · 2006 · Retrovirology
The Risk of Virologic Failure Decreases with Duration of HIV Suppression, at Greater than 50% Adherence to Antiretroviral Therapy
Michael D. Rosenblum, Steven G. Deeks, Mark J. van der Laan, David R. Bangsberg · 2009 · PLoS ONE
Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4 + T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy
Timothy P. Brennan, John O. Woods, Ahmad R. Sedaghat, Janet D'Angelo Siliciano, Robert F. Siliciano, Claus O. Wilke · 2009 · Journal of Virology
Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load
Laurent M. P. F. Humeau, Gwendolyn K. Binder, Xiaobin Lü, Vladimir Slepushkin, Randall K. Merling, Patricia Echeagaray, Mário José dos Santos Pereira, Tatiana Slepushkina, Scott H. Barnett, Lesia K. Dropulic et al. · 2004 · Molecular Therapy
Immunology of pediatric HIV infection
Nicole H. Tobin, Grace M. Aldrovandi · 2013 · Immunological Reviews
Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
Libin Rong, Alan S. Perelson · 2008 · Mathematical Biosciences
HDAC inhibitors in HIV
Fiona Wightman, Paula C. Ellenberg, Melissa J. Churchill, Sharon R. Lewin · 2011 · Immunology and Cell Biology
Recurrent HIV‐1 Integration at theBACH2Locus in Resting CD4+T Cell Populations during Effective Highly Active Antiretroviral Therapy
Terumasa Ikeda, Junji Shibata, Kazuhisa Yoshimura, Atsushi Koito, Shuzo Matsushita · 2007 · The Journal of Infectious Diseases
Regulation of HIV-1 latency by T-cell activation
Samuel A. Williams, Warner C. Greene · 2007 · Cytokine
HIV-1 DNA Is Detected in Bone Marrow Populations Containing CD4+ T Cells but Is not Found in Purified CD34+ Hematopoietic Progenitor Cells in Most Patients on Antiretroviral Therapy
Christine M. Durand, Gabriel Ghiaur, Janet D'Angelo Siliciano, Seyed Alireza Rabi, Evelyn E. Eisele, María Salgado, Shan Liang, Jun Lai, Hao Zhang, Joseph B. Margolick et al. · 2012 · The Journal of Infectious Diseases
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission
Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, Andrew J. Grimm, David A. Cooper, Sharon R. Lewin, Ole Schmeltz Søgaard, Thomas A. Rasmussen, Stephen John Kent, Anthony Dominic Kelleher et al. · 2015 · PLoS Pathogens
A Flexible Model of HIV-1 Latency Permitting Evaluation of Many Primary CD4 T-Cell Reservoirs
Kara G. Lassen, Andrew M. Hebbeler, Darshana Bhattacharyya, Michael A. Lobritz, Warner C. Greene · 2012 · PLoS ONE
Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir
Pilar Mendoza, Julia Jackson, Thiago Y. Oliveira, Christian Gaebler, Víctor Ramos, Marina F. Caskey, Mila Janković, Michel C. Nussenzweig, Lillian B. Cohn · 2020 · The Journal of Experimental Medicine
Intensification of Antiretroviral Therapy Accelerates the Decay of the HIV-1 Latent Reservoir and Decreases, But Does Not Eliminate, Ongoing Virus Replication
Bharat Ramratnam, Ruy Miguel Ribeiro, He Tian, Chris Chung, Viviana R. Simon, Jeroen Vanderhoeven, Arlene Hurley, Linqi Zhang, Alan S. Perelson, David D. Ho et al. · 2003 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV)
Lesley White, Subramaniam Krishnan, Nataša Štrbo, Huanliang Liu, Michael A. Kolber, Mathias Georg Lichtenheld, Rajendra N. Pahwa, Savita G. Pahwa · 2006 · Blood
Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection
Luc Geeraert, Günter Kraus, Roger J. Pomerantz · 2007 · Annual Review of Medicine
Is the central nervous system a reservoir of HIV-1?
Lachlan R. Gray, Michael Roche, Jacqueline K. Flynn, Steve L Wesselingh, Paul R. Gorry, Melissa J. Churchill · 2014 · Current Opinion in HIV and AIDS
Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy
Mariko Horiike, Shingo Iwami, Makoto Kodama, Akihiko Sato, Yuji Watanabe, Mika Yasui, Yuki Ishida, Takeshi Kobayashi, Tomoyuki Miura, Tatsuhiko Igarashi · 2011 · Virology
HIV reservoirs, latency, and reactivation: Prospects for eradication
Viktor Dahl, Lina Josefsson, Sarah Palmer · 2009 · Antiviral Research
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
Xiaodong Lian, Kyra W. Seiger, Elizabeth M. Parsons, Ce Gao, Weiwei Sun, Gregory T. Gladkov, Isabelle C. Roseto, Kevin B. Einkauf, Matthew R. Osborn, Joshua M Chevalier et al. · 2023 · Cell Host & Microbe
Transient Viremia, Plasma Viral Load, and Reservoir Replenishment in HIV-Infected Patients on Antiretroviral Therapy
Laura Jones, Alan S. Perelson · 2007 · JAIDS Journal of Acquired Immune Deficiency Syndromes
HIV reservoirs and latency models
Matthew J. Pace, Luis M. Agosto, Erin H. Graf, Una O’Doherty · 2011 · Virology
Influence of Host Gene Transcription Level and Orientation on HIV-1 Latency in a Primary-Cell Model
Liang Shan, Hung‐Chih Yang, Seyed Alireza Rabi, Héctor Corrada Bravo, Neeta S. Shroff, Rafael A. Irizarry, Hao Zhang, Joseph B. Margolick, Janet D'Angelo Siliciano, Robert F. Siliciano · 2011 · Journal of Virology
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir
Christian Gaebler, Julio C. C. Lorenzi, Thiago Y. Oliveira, Lilian Nogueira, Víctor Ramos, Ching-Lan Lu, Joy A. Pai, Pilar Mendoza, Mila Janković, Marina F. Caskey et al. · 2019 · The Journal of Experimental Medicine
Establishment of latent HIV-1 reservoirs: what do we really know?
Jef Vanhamel, Anne Bruggemans, Zeger Debyser · 2019 · Journal of Virus Eradication
HIV latency and integration site placement in five cell-based models
Scott A. Sherrill-Mix, Mary K. Lewinski, Marylinda Famiglietti, Alberto Bosque, Nirav Malani, Karen E. Ocwieja, Charles C. Berry, David J. Looney, Liang Shan, Luis M. Agosto et al. · 2013 · Retrovirology
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy
Francesca Ferretti, Magnus Gisslén, Paola Maria Cinque, Richard W. Price · 2015 · Current HIV/AIDS Reports
HIV reservoirs and the possibility of a cure for HIV infection
Sarah Palmer, Lina Josefsson, John M. Coffin · 2011 · Journal of Internal Medicine
Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
Alexandra Emilie Duverger, Jennifer Jones, Jori E. May, Frédéric Bibollet‐Ruche, Frederic A. Wagner, Randy Quentin Cron, Olaf Kutsch · 2009 · Journal of Virology
Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
Shay Matalon, Thomas A. Rasmussen, Charles Anthony Dinarello · 2011 · Molecular Medicine
CRISPR-mediated Activation of Latent HIV-1 Expression
Prajit Limsirichai, Thomas Gaj, David V. Schaffer · 2015 · Molecular Therapy
Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA
Francesco Roberto Simonetti, Jennifer A. White, Camille Tumiotto, Kristen D. Ritter, Mian Cai, Rajesh Tim Gandhi, Steven G. Deeks, Bonnie J. Howell, Luis J. Montaner, Joel N. Blankson et al. · 2020 · Proceedings of the National Academy of Sciences
Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region
Suzuki, Kazuo, Juelich, Torsten, Lim, Heidi, Ishida, Takaomi, Watanebe, Toshiki, Cooper, David A., Rao, Sudha, Kelleher, Anthony D. · 2008 · Journal of Biological Chemistry
Paediatric HIV infection: the potential for cure
Philip Goulder, Sharon R. Lewin, Ellen M. Leitman · 2016 · Nature reviews. Immunology
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
Xiancai Ma, Tao Yang, Yuewen Luo, Liyang Wu, Yawen Jiang, Zheng Song, Ting Shuang Pan, Bingfeng Liu, Guangyan Liu, Jun Liu et al. · 2019 · eLife
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection
Louise Leyre, Eugene D. M. B. Kroon, Claire Vandergeeten, Carlo Sacdalan, Donn J. Colby, Supranee Buranapraditkun, Alexandra Schuetz, Nitiya Chomchey, Mark S. de Souza, Wendy Bakeman et al. · 2020 · Science Translational Medicine